Late metastatic presentation is associated with improved survival and delayed wide-spread progression after ablative stereotactic body radiotherapy for oligometastasis.
Xuguang ChenHanbo ChenIan PoonDarby ErlerSerena BadellinoTithi BiswasRoi DaganMatthew FooteAlexander V LouieUmberto RicardiArjun SahgalKristin Janson RedmondPublished in: Cancer medicine (2021)
Late metastatic presentation is associated with improved survival and delayed progression in patients with OMD treated with SBRT.